SCHEMBL4562704

SCHEMBL4562704

O=S(=O)(c1ccccc1C(F)(F)F)C1CNCCN1S(=O)(=O)c1ccccc1C(F)(F)F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.52
▸ MEN1 O00255 2/20 0.52
▸ HTR6 P50406 2/20 0.42
▸ HCRTR1 O43613 1/20 0.42
▸ HTR2C P28335 6/20 0.39
▸ HTR2B P41595 6/20 0.39
▸ HTR2A P28223 4/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ TRPV4 Q9HBA0 1/20 0.38
▸ PRKD3 O94806 1/20 0.38
▸ PRKCG P05129 1/20 0.38
▸ PRKCB P05771 1/20 0.38
▸ PRKCA P17252 1/20 0.38
▸ PRKACA P17612 1/20 0.38
▸ PRKACG P22612 1/20 0.38
▸ PRKACB P22694 1/20 0.38
▸ PRKCH P24723 1/20 0.38
▸ PRKCI P41743 1/20 0.38
▸ PRKCE Q02156 1/20 0.38
▸ PRKCQ Q04759 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30150292 0.76 KMT2A (0.79) KMT2AMEN1HTR6ALDH1A1PRKD3
SCHEMBL4551056 0.76 KMT2A (0.79) KMT2AMEN1HTR6ALDH1A1PRKD3
SCHEMBL22489549 0.75 KMT2A (0.44) KMT2AMEN1HTR6HCRTR1HTR2C
SCHEMBL2685141 0.73 SFRP1 (0.47) KMT2AMEN1HTR2CSLC6A2SLC6A4
SCHEMBL2685137 0.73 SFRP1 (0.47) KMT2AMEN1HTR2CSLC6A2SLC6A4
SCHEMBL18672672 0.73 PRKACA (0.56) KMT2AMEN1HCRTR1ALDH1A1PRKD3
SCHEMBL29500391 0.70 KMT2A (0.56) KMT2AMEN1HTR6HCRTR1HTR2C
SCHEMBL19640879 0.70 KMT2A (0.56) KMT2AMEN1HTR6HCRTR1HTR2C
SCHEMBL8483131 0.70 HTR2C (0.51) KMT2AMEN1HTR2CSLC6A2SLC6A4
Hydrochloric Acid SCHEMBL70687 0.69 HTR2C (0.53) KMT2AMEN1HTR2CSLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247499-A1 SULFONYLATED PIPERAZINES AS CANNABINOID-1 RECEPTOR MODULATORS MERCK SHARP & DOHME CORP. 2009-10-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247499-A1 SULFONYLATED PIPERAZINES AS CANNABINOID-1 RECEPTOR MODULATORS CNR1, CNR2, FAAH KMT2A 2133/4885MEN1 430/4885HTR6 432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback